The detection rates for mutations in the 264 patients with adenocarcinoma, excluding the three cases in which the mutations could not be determined by DNA or RNA, are shown in Figure 1, with details of the EGFR mutations presented in Table 2. Here, EGFR is linked to adenocarcinoma.